122 related articles for article (PubMed ID: 14551356)
1. Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?
Boner G; Cox AJ; Kelly DJ; Tobar A; Bernheim J; Langham RG; Cooper ME; Gilbert RE
Nephrol Dial Transplant; 2003 Nov; 18(11):2293-9. PubMed ID: 14551356
[TBL] [Abstract][Full Text] [Related]
2. Nephrotic syndrome unfavorable course correlates with downregulation of podocyte vascular endothelial growth factor receptor (VEGFR)-2.
Ostalska-Nowicka D; Malinska A; Zabel M; Witkiewicz W; Nowicki M
Folia Histochem Cytobiol; 2011; 49(3):472-8. PubMed ID: 22038228
[TBL] [Abstract][Full Text] [Related]
3. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
5. Histopathological spectrum of childhood nephrotic syndrome in Indian children.
Kumar J; Gulati S; Sharma AP; Sharma RK; Gupta RK
Pediatr Nephrol; 2003 Jul; 18(7):657-60. PubMed ID: 12743793
[TBL] [Abstract][Full Text] [Related]
6. Role of vascular endothelial growth factor A in children with acquired airway stenosis.
Rahbar R; Brown LF; Folkman J; McGill TJ; Healy GB; Liu G; Vargas SO
Ann Otol Rhinol Laryngol; 2007 Jun; 116(6):430-5. PubMed ID: 17672245
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical distribution of endothelin in biopsies of pediatric nephrotic syndrome.
Murer L; Zacchello G; Basso G; Scarpa A; Montini G; Chiozza ML; Zacchello F
Am J Nephrol; 1994; 14(3):157-61. PubMed ID: 7977473
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic study of the cases of minimal change nephrotic syndrome with mesangial IgA deposition.
Jeong HJ; Jung SH; Choi IJ
Yonsei Med J; 1992 Dec; 33(4):351-6. PubMed ID: 1309015
[TBL] [Abstract][Full Text] [Related]
9. Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis.
Rahbar R; Vargas SO; Folkman J; McGill TJ; Healy GB; Tan X; Brown LF
Ann Otol Rhinol Laryngol; 2005 Apr; 114(4):289-95. PubMed ID: 15895784
[TBL] [Abstract][Full Text] [Related]
10. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
11. Minimal change disease as the etiology of the nephrotic syndrome in a patient with angioimmunoblastic lymphadenopathy.
Staszewski H; Kumar G; Mishriki Y
Med Pediatr Oncol; 1988; 16(3):206-9. PubMed ID: 3380062
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, -a common cause of nephrotic syndrome.
Yan G; Liu G; Tian X; Tian L; Wang H; Ren P; Ma X; Fu R; Chen Z
BMC Nephrol; 2020 Sep; 21(1):396. PubMed ID: 32928127
[TBL] [Abstract][Full Text] [Related]
13. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
14. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
16. Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy.
Chen WP; Lin CY
Nephron; 1994; 68(1):10-9. PubMed ID: 7991018
[TBL] [Abstract][Full Text] [Related]
17. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
18. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
[TBL] [Abstract][Full Text] [Related]
19. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
Looi LM; Wang F; Lam KL; Chua CT
Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
[TBL] [Abstract][Full Text] [Related]
20. Reversible minimal change nephrotic syndrome and glomerular IgA deposition associated with nonparenteral heroin abuse: a case report.
Turgutalp K; Kiykim A; Karabulut U; Gursoy D; Gurses I
Med Princ Pract; 2012; 21(5):492-4. PubMed ID: 22539034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
